True Wealth Design’s Novavax NVAX Stock Holding History

True Wealth Design’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.85K	Buy	196 +187	+2,078%	+$1.68K	﹤0.01%	1717
2026 Q1	$74	Buy	+9	New	+$82	﹤0.01%	2513

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

True Wealth Design's NVAX Position: Q2 2026 in Review

True Wealth Design increased its Novavax (NVAX) stake by 2,078% in Q2 2026, buying an estimated $1.68K and bringing the position to 196 shares worth $1.85K. The position accounts for ﹤0.01% of the portfolio, ranked #1717.

True Wealth Design first reported a position in NVAX in Q1 2026 and has held it in 2 quarters since. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

True Wealth Design held 196 shares of Novavax worth $1.85K as of Q2 2026.
True Wealth Design bought 187 Novavax shares in Q2 2026, an estimated $1.68K.
Novavax made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1717 holding.
True Wealth Design first reported a position in Novavax in Q1 2026 and has held it in 2 quarters since.
266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.